Dr. Eric David Johnson, MD

Dr. Johnson practices at Intermountain Cancer Center at McKay-Dee in Ogden, Utah.

Dr. Johnson's NPI, 1649665399, was assigned on March 31, 2015. Dr. Johnson graduated from George Washington University School of Medicine in 2015. Dr. Johnson holds Utah license 1649665399.

Dr. Johnson's primary practice is Intermountain Cancer Center at McKay-Dee, at 4403 Harrison Blvd, Ogden, UT 84403 in Weber County. The practice phone is (801) 387-7150.

Dr. Johnson's primary practice is Intermountain Cancer Center at McKay-Dee in Ogden, Utah. Dr. Johnson is also affiliated with McKay-Dee Hospital. The medical group on file is Intermountain Health. Dmand AI also links Dr. Johnson to 4 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Johnson practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Johnson's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Johnson is licensed in Utah.

CMS data shows 1,299 Medicare services from Dr. Johnson across 4 procedure codes in 2024, for 230 Medicare patients. Medicare paid $87,528 for them. Every service was in an office.

CMS counts 230 Medicare patients who saw Dr. Johnson in 2024. The largest group is 65 to 74, with 106 patients. 70% of them have high blood pressure, and 67% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Johnson's median patient age at 71, with 66% women.

In 2024, Dr. Johnson wrote 1,331 Medicare Part D claims for 206 patients. 78% of them were for generic drugs. CMS names the drug for 948 of them, across 30 drugs with 11 or more claims each, at $2,250,925 in total drug cost. In 2023, CMS named 715 claims across 26 drugs.

Dr. Johnson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Johnson as offering telehealth.

Dmand AI links 11 papers to Dr. Johnson, published from 2016 to 2022. 2017 was the busiest year, with 2. Dr. Johnson has published most often in Case Rep Oncol. Dr. Johnson's most frequent co-authors are Saundra S. Buys, MD, Sarah V. Colonna, MD and Sumati Virendra Gupta, MD.

CMS Open Payments shows 34 general payments to Dr. Johnson from 12 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 49% of the total. BTG International, Inc. paid the most, $13,854.

Dr. Johnson graduated from George Washington University School of Medicine in 2015.